Toxic megacolon epidemiology and demographics
|
Toxic Megacolon Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic megacolon epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Toxic megacolon epidemiology and demographics |
|
Risk calculators and risk factors for Toxic megacolon epidemiology and demographics |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic megacolon epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Toxic megacolon epidemiology and demographics |
|
Risk calculators and risk factors for Toxic megacolon epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The precise incidence of toxic megacolon is unknown in general population. The incidence of toxic megacolon in the associated disorders including ulceritive colitis and crohn's disease is:[1][2]
- 1000-2500 in 100,000 cases of the ulcerative colitis
- 4400-6300 in 100,000 cases of the Crohn's disease
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Mortality rate
- The mortality rate of toxic megacolon associated with clostridium difficile is approximately %64-%67.
- The mortality rate of toxic megacolon associated with pseudomembranous colitis is approximately
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Gan, S. Ian; Beck, P. L. (2003). "A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management". The American Journal of Gastroenterology. 98 (11): 2363–2371. doi:10.1111/j.1572-0241.2003.07696.x. ISSN 0002-9270.
- ↑ Grieco MB, Bordan DL, Geiss AC, Beil AR (1980). "Toxic megacolon complicating Crohn's colitis". Ann. Surg. 191 (1): 75–80. PMC 1344622. PMID 7352781.
References